ArticleInternational journal of molecular sciences2022

Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification.

Khayal Gasimli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.